Investor Statements Overview
How Investor Statements Work
Through our policy workstream, we aim to promote a greater understanding of ESG risks in intensive animal agriculture and to draw attention to sustainable policies and practices. As an investor member, you can sign on to any of FAIRR’s investor statements to show your support and create an impact through your support on key issues. Complete the signatory form to sign the statement or reach out to our team for further details.
A new investor statement has launched: G20 Agricultural Subsidies Statement
In light of the recent Global Biodiversity Framework, FAIRR has put together an investor statement calling on the G20 Finance Ministers to repurpose their agricultural subsidies in line with climate and nature goals. Engagement has already begun with G20 finance ministers, including those in the UK and the US.
G20 Agricultural Subsidies Statement
FAIRR has put together an investor statement calling on the G20 Finance Ministers to repurpose their agricultural subsidies in line with climate and nature goals.
In this letter, investors and financial advisers representing over $3.5 trillion in assets, sent a letter to the EU Commission, summing up concerns over certain elements of the EU Taxonomy, and drawing attention to the importance of the agriculture sector.
Global Roadmap to 2050 for Food and Agriculture
In this letter, investors representing $18 trillion in combined assets called on the FAO to produce a Global Roadmap to 1.5˚C, Nature and Nutrition Security Goals.
Amazon Soy Moratorium
The letter calls for the protection of the ‘Amazon Soy Moratorium’, an agreement signed in 2006 to ensure that soy production in the Amazon region only occurs on existing converted agricultural land and not through deforestation of native vegetation.
The Statement recognised the need to prevent further deforestation in the Cerrado to mitigate future risks associated with climate change and agricultural resilience in this important agricultural production region.
With this statement, we aim to demonstrate investor support for antibiotics stewardship policies while helping companies to use antibiotics in a safer way.